NCT02597998View on ClinicalTrials.gov

Metabolism and Pharmacokinetics of [14C]-BI 409306 After Administration as Oral Solution in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 15, 2015

Primary Completion Date

December 11, 2015

Study Completion Date

December 11, 2015

Conditions
Healthy
Interventions
DRUG

14C-BI 409306

Trial Locations (1)

NG11 6JS

Quotient Sciences, Nottingham

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY